Litcius/Paper detail

Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019

Eri Ito, Shoji Saito, Masaki Okazaki, Yuki Toyama, Takuji Ishimoto, Tomoki Kosugi, Hiroaki Hiraiwa, Naruhiro Jingushi, Takanori Yamamoto, Masayuki Ozaki, Yukari Goto, Atsushi Numaguchi, Yasuhiro Miyagawa, Io Kato, Nobuyuki Tetsuka, Tetsuya Yagi, Shoichi Maruyama

2020CEN Case Reports32 citationsDOIOpen Access PDF

Topics & Concepts

FavipiravirMedicineLopinavirHemodialysisEnd stage renal diseaseInternal medicinePneumoniaRitonavirIntensive care medicineDiseaseViral loadImmunologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)VirusAntiretroviral therapyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRespiratory viral infections research
Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019 | Litcius